Picture of CellSource Co logo

4880 CellSource Co Cashflow Statement

0.000.00%
jp flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapFalling Star

Annual cashflow statement for CellSource Co, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.

2019
October 31st
2020
October 31st
2021
October 31st
2022
October 31st
2023
October 31st
Period Length:12 M12 M12 M12 M12 M
Source:YuhoYuhoYuhoYuhoYuho
Standards:
JAS
JAS
JAS
JAS
JAS
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line3034131,0061,5841,240
Depreciation
Non-Cash Items73.646.219.363.348.3
Unusual Items
Other Non-Cash Items
Changes in Working Capital-202-155-158-845-505
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Accounts Payable
Change in Other Liabilities
Other Operating Cash Flow
Cash from Operating Activities195330898848847
Capital Expenditures-53.4-32.7-61.5-99.2-359
Purchase of Fixed Assets
Purchase / Acquisition of Intangibles
Other Investing Cash Flow Items-54.5-25.1-195-70.2-265
Sale/Maturity of Investment
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-108-57.8-256-169-624
Financing Cash Flow Items-7.89-1.560.8020.252-6
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities9931539.3514.41,449
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash1,0814236527141,657